{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:24:41Z","timestamp":1781234681631,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000936","name":"Gordon and Betty Moore Foundation","doi-asserted-by":"publisher","award":["GBMF9048"],"award-info":[{"award-number":["GBMF9048"]}],"id":[{"id":"10.13039\/100000936","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.burns.2025.107571","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T06:31:06Z","timestamp":1749105066000},"page":"107571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Persistent inflammation, immunosuppression, and catabolism syndrome and sepsis in pediatric burns"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9869-5741","authenticated-orcid":false,"given":"Michael D.","family":"Santarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2797-6508","authenticated-orcid":false,"given":"Alvin D.","family":"Jeffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie G.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1529-9872","authenticated-orcid":false,"given":"Prince J.","family":"Kannankeril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth D.","family":"Slater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3644-6755","authenticated-orcid":false,"given":"Anne L.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6142-5502","authenticated-orcid":false,"given":"Ryan J.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.burns.2025.107571_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cpem.2014.04.004","article-title":"Burn sepsis in children","volume":"15","author":"Tran","year":"2014","journal-title":"Clin Pediatr Emerg Med"},{"key":"10.1016\/j.burns.2025.107571_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkaa047","article-title":"The pathogenesis and diagnosis of sepsis post burn injury","volume":"9","author":"Zhang","year":"2021","journal-title":"Burns Trauma"},{"key":"10.1016\/j.burns.2025.107571_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s41038-017-0089-5","article-title":"Sepsis in the burn patient: a different problem than sepsis in the general population","volume":"5","author":"Greenhalgh","year":"2017","journal-title":"Burns Trauma"},{"issue":"3","key":"10.1016\/j.burns.2025.107571_bib4","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1097\/01.PCC.0000161577.27849.BE","article-title":"Sepsis in pediatric burn patients","volume":"6","author":"Sheridan","year":"2005","journal-title":"Pedia Crit Care Med"},{"issue":"6","key":"10.1016\/j.burns.2025.107571_bib5","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/TA.0b013e318256e000","article-title":"Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care","volume":"72","author":"Gentile","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"10.1016\/j.burns.2025.107571_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jhn.12798","article-title":"Persistent inflammation, immunosuppression and catabolism syndrome (PICS) in critically ill children is associated with clinical outcomes: a prospective longitudinal study","volume":"34","author":"Hauschild","year":"2021","journal-title":"J Hum Nutr Diet"},{"issue":"5","key":"10.1016\/j.burns.2025.107571_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/nri3660","article-title":"Emergency granulopoiesis","volume":"14","author":"Manz","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.burns.2025.107571_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28409-7","article-title":"Innate and adaptive immune dysregulation in critically ill ICU patients","volume":"8","author":"Duggal","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.burns.2025.107571_bib9","article-title":"Persistent inflammation, immunosuppression, and catabolism syndrome in pediatric populations: a brief perspective","author":"Santarelli","year":"2024","journal-title":"Curr Pedia Rev"},{"issue":"5","key":"10.1016\/j.burns.2025.107571_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41590-023-01490-5","article-title":"Neutorphils and emergency granulopoiesis drive immun suppression and an extreme response endotype during sepsis","volume":"24","author":"Kwok","year":"2023","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.burns.2025.107571_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40635-020-00309-z","article-title":"Role of the adaptive immune response in sepsis","volume":"8","author":"Brady","year":"2020","journal-title":"Intensive Care Med Exp"},{"issue":"2","key":"10.1016\/j.burns.2025.107571_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/SHK.0000000000002019","article-title":"Neutrophil heterogeneity in sepsis: the role of Damage-Associated molecular patterns","volume":"59","author":"Murao","year":"2023","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.burns.2025.107571_bib13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ni.3398","article-title":"Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis","volume":"17","author":"Cheng","year":"2016","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.burns.2025.107571_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MOP.0000000000000337","article-title":"Pediatric sepsis","volume":"28","author":"Mathias","year":"2016","journal-title":"Curr Opin Pedia"},{"issue":"5","key":"10.1016\/j.burns.2025.107571_bib15","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.chest.2023.05.002","article-title":"Pediatric persistent inflammation, immunosuppression, and catabolism syndrome prevalence in Sepsis-Related mortalities: a 23-Year institutional history","volume":"164","author":"Patterson","year":"2023","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.burns.2025.107571_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bja.2023.11.052","article-title":"Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities","volume":"132","author":"Chadda","year":"2024","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.burns.2025.107571_bib17","article-title":"Cytokines and metabolic patterns in pediatric patients with critical illness","volume":"2010","author":"Briassoulis","year":"2010","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"10.1016\/j.burns.2025.107571_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/SHK.0000000000000981","article-title":"Evidence for persistent immune suppression in patients who develop chronic critical illness after sepsis","volume":"49","author":"Stortz","year":"2018","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.burns.2025.107571_bib19","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/00003246-200004000-00042","article-title":"Energy expenditure in critically ill children","volume":"28","author":"Briassoulis","year":"2000","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.burns.2025.107571_bib20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/TA.0000000000004087","article-title":"The persistent inflammation, immunosuppression, and catabolism syndrome 10 years later","volume":"95","author":"Efron","year":"2023","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"10.1016\/j.burns.2025.107571_bib21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/clpt.2008.89","article-title":"Development of a large-scale de-identified DNA biobank to enable personalized Medicine","volume":"84","author":"Roden","year":"2008","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.burns.2025.107571_bib22","unstructured":"Institute N.H.L.B. Lymphopenia. Updated May 31, 2022. Accessed August 8, 2024."},{"issue":"12","key":"10.1016\/j.burns.2025.107571_bib23","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/CCM.0000000000005993","article-title":"Early, persistent lymphopenia is associated with prolonged multiple organ failure and mortality in septic children","volume":"51","author":"Podd","year":"2023","journal-title":"Crit Care Med"},{"issue":"9596","key":"10.1016\/j.burns.2025.107571_bib24","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.burns.2025.107571_bib25","series-title":"Update: Report of Data","article-title":"Annual burn injury summary report","author":"Association AB","year":"2023"},{"key":"10.1016\/j.burns.2025.107571_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.586195","article-title":"Severe altered immune status after burn injury is associated with bacterial infection and septic shock","volume":"12","author":"Moins-Teisserenc","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.burns.2025.107571_bib27","first-page":"554","article-title":"Mortality determinants in massive pediatric burns","volume":"225","author":"Wolf","year":"1997","journal-title":"Anal 103 Child > = 80% TBSA Burns (> = 70% FullThick) Ann Surg"},{"issue":"3","key":"10.1016\/j.burns.2025.107571_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jbcr\/irz017","article-title":"Outcomes in Burn-Injured patients who develop sepsis","volume":"40","author":"Rech","year":"2019","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2025.107571_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s41038-018-0132-1","article-title":"Valuable prognostic indicators for severe burn sepsis with inhalation lesion: age, platelet count, and procalcitonin","volume":"6","author":"Xu","year":"2018","journal-title":"Burns Trauma"},{"issue":"3","key":"10.1016\/j.burns.2025.107571_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","article-title":"Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome","volume":"37","author":"Hall","year":"2011","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.burns.2025.107571_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00000658-197709000-00002","article-title":"Delayed hypersensitivity: indicator of acquired failure of host defences in sepsis and trauma","volume":"186","author":"Meakins","year":"1977","journal-title":"Ann Surg"},{"issue":"3_1","key":"10.1016\/j.burns.2025.107571_bib32","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/PCC.0000000000001052","article-title":"Pathophysiology of pediatric multiple organ dysfunction syndrome","volume":"18","author":"Carcillo","year":"2017","journal-title":"Pedia Crit Care Med"},{"issue":"6","key":"10.1016\/j.burns.2025.107571_bib33","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.4049\/jimmunol.174.6.3765","article-title":"Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure","volume":"174","author":"Felmet","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.burns.2025.107571_bib34","article-title":"Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): a new phenotype of multiple organ failure","volume":"1","author":"Rosenthal","year":"2015","journal-title":"J Adv Nutr Hum Metab"},{"issue":"4","key":"10.1016\/j.burns.2025.107571_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000658-200010000-00001","article-title":"Determinants of skeletal muscle catabolism after severe burn","volume":"232","author":"Hart","year":"2000","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.burns.2025.107571_bib36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/SLA.0b013e3181856241","article-title":"Pathophysiologic response to severe burn injury","volume":"248","author":"Jeschke","year":"2008","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.burns.2025.107571_bib37","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00000658-200106000-00013","article-title":"Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy","volume":"233","author":"Hart","year":"2001","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.burns.2025.107571_bib38","first-page":"2705","article-title":"Short-term oxandrolone administration stimulates net muscle protein synthesis in young men","volume":"84","author":"Sheffield-Moore","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.burns.2025.107571_bib39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jamcollsurg.2011.12.038","article-title":"Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy","volume":"214","author":"Porro","year":"2012","journal-title":"J Am Coll Surg"},{"issue":"17","key":"10.1016\/j.burns.2025.107571_bib40","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa010342","article-title":"Reversal of catabolism by beta-blockade after severe burns","volume":"345","author":"Herndon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.burns.2025.107571_bib41","unstructured":"88 Determination That Oxandrin (Oxandrolone) Tablets, 2.5 Milligrams and 10 Milligrams, Were Withdrawn From Sale for Reasons of Safety or Effectiveness (Federal Register) (2023)."},{"issue":"1","key":"10.1016\/j.burns.2025.107571_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/cc10031","article-title":"Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis","volume":"15","author":"Bo","year":"2011","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.burns.2025.107571_bib43","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial","volume":"180","author":"Meisel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.burns.2025.107571_bib44","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/s41423-021-00719-3","article-title":"Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19","volume":"18","author":"Mu","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.burns.2025.107571_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13613-023-01109-w","article-title":"Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial","volume":"13","author":"Daix","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.burns.2025.107571_bib46","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1186\/s12879-019-4526-x","article-title":"Multicentric experience with interferon gamma therapy in sepsis induced immunosuppression. A case series","volume":"19","author":"Payen","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"1_","key":"10.1016\/j.burns.2025.107571_bib47","first-page":"121S","article-title":"Nutrition support for persistent inflammation, immunosuppression, and catabolism syndrome","volume":"32","author":"Moore","year":"2017","journal-title":"Nutr Clin Pr"},{"key":"10.1016\/j.burns.2025.107571_bib48","article-title":"Hypercatabolism and Anti-catabolic therapies in the persistent inflammation, immunosuppression, and catabolism syndrome","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Nutr"},{"issue":"3","key":"10.1016\/j.burns.2025.107571_bib49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/0884533609336604","article-title":"The evolving rationale for early enteral nutrition based on paradigms of multiple organ failure: a personal journey","volume":"24","author":"Moore","year":"2009","journal-title":"Nutr Clin Pr"},{"issue":"11","key":"10.1016\/j.burns.2025.107571_bib50","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa2203364","article-title":"A randomized trial of enteral glutamine for treatment of burn injuries","volume":"387","author":"Heyland","year":"2022","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.burns.2025.107571_bib51","doi-asserted-by":"crossref","first-page":"844","DOI":"10.7326\/0003-4819-119-8-199310150-00011","article-title":"Discordance of databases designed for claims payment versus clinical information systems. Implications for outcomes research","volume":"119","author":"Jollis","year":"1993","journal-title":"Ann Intern Med"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417925002001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417925002001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T23:42:52Z","timestamp":1751586172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417925002001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0305417925002001"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2025.107571","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent inflammation, immunosuppression, and catabolism syndrome and sepsis in pediatric burns","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2025.107571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107571"}}